Health tech deals
Automata has raised US$45m in a series C round to accelerate its lab automation platform for life sciences. The London-based company is building fully integrated, AI-ready platforms that combine modular robotics, orchestration software and unified data infrastructure to turn physical labs into programmable systems. The company said the funding will be used to scale customer [...]
Mos Health has raised about €920k (US$1.1m) in pre-seed funding for an AI preventative health platform aimed at helping users stick to healthier habits. The Polish-American startup is building what it calls an “AI Health Partner”, combining personalised health protocols, or step-by-step plans, with matched supplements to support routine changes. Mos Health says it is [...]
Procter & Gamble has acquired Wonderbelly, adding the digestive wellness brand to its over-the-counter portfolio. Wonderbelly sells products including antacids, gas and bloat relief, and multi-symptom relief treatments. The range is marketed as free of artificial dyes, talc, titanium dioxide, artificial sweeteners and parabens. The vegan, non-GMO products include flavours such as Strawberry [...]
Corxel has raised US$287m in a series D to fund phase 2 studies of its oral GLP-1 receptor agonist for obesity and support planned phase 3 trials. GLP-1 receptor agonists are medicines that mimic a natural hormone to help control blood sugar and reduce appetite, and have become a major focus in the weight-loss market. [...]
Medtronic has finalised a US$90m investment in Anteris Technologies, a Minnesota medtech firm developing TAVR valve technology. Anteris focuses on structural heart technologies and is known for its biomimetic DurAVR transcatheter heart valve (THV) system, which the company says is the first of its kind. The DurAVR valve is made from a single piece of [...]
PharmaForceIQ has announced its acquisition of Aktana, aligning its cutting-edge digital orchestration platform with the industry’s premier AI-driven field Next-Best-Action (NBA) platform. The strategic move creates the industry’s first optichannel-in-a-box solution for pharma companies – an end-to-end commercial customer engagement system that can go live in as little as 6–8 weeks. This becomes the most [...]
Medtronic will invest up to US$90m in Anteris Technologies to help fund the next stage of growth and the DurAVR transcatheter heart valve programme. The Australia-founded company said the funding will support execution of its clinical strategy for DurAVR, designed to mimic a healthy human aortic valve and replicate normal aortic blood flow. Transcatheter heart [...]
ErVimmune has announced a first closing of a €17m Series A to develop cancer vaccines for ‘cold tumours’ that often fail to respond to immunotherapies. The Lyon-based biotech is developing therapeutic vaccines and cell therapies for cold tumours, a term used for cancers that tend to evade immune-based treatments. The funding will support clinical development [...]
Kinaset Therapeutics has raised US$103m in a Series B to move forward frevecitinib, an inhaled asthma therapy for people not controlled by standard inhalers. The Boston-based firm is developing an inhaled treatment for serious respiratory diseases. The company will use the proceeds to advance frevecitinib, an inhaled dry powder being developed for people whose asthma [...]
QV Bioelectronics has secured £4.5m in investment and grant funding to develop what it calls a world-first glioblastoma implant. Cheshire-based medtech QV Bioelectronics said the funding will support an implantable device intended to improve outcomes for patients with glioblastoma. Glioblastoma, or GBM, is an aggressive brain tumour. Cancer Research UK says it accounted for about [...]
